← All trials
NCT02947100
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jan 1, 2017
- Primary completion
- Apr 1, 2019
- Completion date
- Apr 1, 2019
- First posted
- —
- Last posted
- —
- Enrollment
- 42
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Nemours Children's Health SystemLead sponsor
- Thomas Jefferson UniversityOverall official - principal investigator
- Thomas Jefferson UniversitySponsor investigator
- National Institute of General Medical Sciences (NIGMS)Collaborator
- Thomas Jefferson UniversityCollaborator
- Solutex GC, S.L.Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.